| The aurora kinases in cell cycle and leukemia B Goldenson, JD Crispino Oncogene 34 (5), 537-545, 2015 | 401 | 2015 |
| 1α, 25-Dihydroxyvitamin D 3 interacts with curcuminoids to stimulate amyloid-β clearance by macrophages of Alzheimer's disease patients A Masoumi, B Goldenson, S Ghirmai, H Avagyan, J Zaghi, K Abel, ... Journal of Alzheimer's disease 17 (3), 703-717, 2009 | 306 | 2009 |
| Identification of regulators of polyploidization presents therapeutic targets for treatment of AMKL Q Wen, B Goldenson, SJ Silver, M Schenone, V Dancik, Z Huang, ... Cell 150 (3), 575-589, 2012 | 161 | 2012 |
| Targeting megakaryocytic-induced fibrosis in myeloproliferative neoplasms by AURKA inhibition Q Jeremy Wen, Q Yang, B Goldenson, S Malinge, T Lasho, RK Schneider, ... Nature medicine 21 (12), 1473-1480, 2015 | 155 | 2015 |
| Alzheimer disease macrophages shuttle amyloid-beta from neurons to vessels, contributing to amyloid angiopathy J Zaghi, B Goldenson, M Inayathullah, AS Lossinsky, A Masoumi, ... Acta neuropathologica 117, 111-124, 2009 | 131 | 2009 |
| AKT is a therapeutic target in myeloproliferative neoplasms I Khan, Z Huang, Q Wen, MJ Stankiewicz, L Gilles, B Goldenson, ... Leukemia 27 (9), 1882-1890, 2013 | 86 | 2013 |
| Immune blood biomarkers of Alzheimer disease patients H Avagyan, B Goldenson, E Tse, A Masoumi, V Porter, M Wiedau-Pazos, ... Journal of neuroimmunology 210 (1-2), 67-72, 2009 | 78 | 2009 |
| VLDL hydrolysis by LPL activates PPAR-α through generation of unbound fatty acids MA Ruby, B Goldenson, G Orasanu, TP Johnston, J Plutzky, RM Krauss Journal of lipid research 51 (8), 2275-2281, 2010 | 76 | 2010 |
| iPSC-derived natural killer cell therapies-expansion and targeting BH Goldenson, P Hor, DS Kaufman Frontiers in immunology 13, 841107, 2022 | 68 | 2022 |
| Perturbation of fetal hematopoiesis in a mouse model of Down syndrome’s transient myeloproliferative disorder Y Birger, L Goldberg, TM Chlon, B Goldenson, I Muler, G Schiby, ... Blood, The Journal of the American Society of Hematology 122 (6), 988-998, 2013 | 56 | 2013 |
| Umbilical cord blood and iPSC-derived natural killer cells demonstrate key differences in cytotoxic activity and KIR profiles BH Goldenson, H Zhu, YZM Wang, N Heragu, D Bernareggi, ... Frontiers in immunology 11, 561553, 2020 | 47 | 2020 |
| Global transcriptome and chromatin occupancy analysis reveal the short isoform of GATA1 is deficient for erythroid specification and gene expression TM Chlon, M McNulty, B Goldenson, A Rosinski, JD Crispino Haematologica 100 (5), 575, 2015 | 42 | 2015 |
| Normal and malignant megakaryopoiesis Q Wen, B Goldenson, JD Crispino Expert reviews in molecular medicine 13, e32, 2011 | 41 | 2011 |
| Aurora kinase A is required for hematopoiesis but is dispensable for murine megakaryocyte endomitosis and differentiation B Goldenson, G Kirsammer, MJ Stankiewicz, QJ Wen, JD Crispino Blood, The Journal of the American Society of Hematology 125 (13), 2141-2150, 2015 | 32 | 2015 |
| Gemtuzumab ozogamicin for the treatment of acute myeloid leukemia in adults BH Goldenson, AM Goodman, ED Ball Expert Opinion on Biological Therapy 21 (7), 849-862, 2021 | 18 | 2021 |
| Integrative screening approach identifies regulators of polyploidization and targets for acute megakaryocytic leukemia Q Wen, B Goldenson, SJ Silver, M Schenone, V Dancik, Z Huang, ... Cell 150 (3), 575, 2012 | 12 | 2012 |
| Into the multiverse of gene edited NK cell-based therapeutic strategies BH Goldenson, DS Kaufman Cell Stem Cell 28 (12), 2041-2043, 2021 | 7 | 2021 |
| Non-relapse mortality in TP53-mutated MDS/AML-a multi-center collaborative study MT Byrne, TJ Kurian, DA Patel, R Tamari, S Hong, H Abdelhakim, V Klein, ... Blood 138, 2922, 2021 | 4 | 2021 |
| Aurora A kinase is a novel therapeutic target in the myeloproliferative neoplasms QJ Wen, B Goldenson, S Malinge, BL Stein, TL Lasho, L Breyfogle, ... Blood, The Journal of the American Society of Hematology 122 (21), 109-109, 2013 | 4 | 2013 |
| Knock-in of the BCL2 G101V mutation in human iPSC-derived NK cells generates venetoclax resistance and improves activity against venetoclax resistant AML D Bernareggi, J Yun, B Goldenson, DS Kaufman Blood 140 (Supplement 1), 7407-7408, 2022 | 2 | 2022 |
